Apigenin suppresses cancer cell growth through ERβ

Paul Mak, Yuet Kin Leung, Wan-Yee Tang, Charlotte Harwood, Shuk Mei Ho

Research output: Contribution to journalArticle

Abstract

Two flavonoids, genistein and apigenin, have been implicated as chemopreventive agents against prostate and breast cancers. However, the mechanisms behind their respective cancer-protective effects may vary significantly. The goal of this study was to determine whether the antiproliferative action of these flavonoids on prostate (DU-145) and breast (MDA-MB-231) cancer cells expressing only estrogen receptor (ER) β is mediated by this ER subtype. It was found that both genistein and apigenin, although not 17β-estradiol, exhibited antiproliferative effects and proapoptotic activities through caspase-3 activation in these two cell lines. In yeast transcription assays, both flavonoids displayed high specificity toward ERβ transactivation, particularly at lower concentrations. However, in mammalian assay, apigenin was found to be more ERβ-selective than genistein, which has equal potency in inducing transactivation through ERα and ERβ. Small interfering RNA-mediated downregulation of ERβ abrogated the antiproliferative effect of apigenin in both cancer cells but did not reverse that of genistein. Our data unveil, for the first time, that the anticancer action of apigenin is mediated, in part, by ERβ. The differential use of ERα and ERβ signaling for transaction between genistein and apigenin demonstrates the complexity of phytoestrogen action in the context of their anticancer properties.

Original languageEnglish (US)
Pages (from-to)896-904
Number of pages9
JournalNeoplasia
Volume8
Issue number11
DOIs
Publication statusPublished - Nov 2006
Externally publishedYes

    Fingerprint

Keywords

  • Apoptosis
  • Cancer chemoprevention
  • ERα
  • Genistein
  • Phytoestrogens

ASJC Scopus subject areas

  • Cancer Research

Cite this

Mak, P., Leung, Y. K., Tang, W-Y., Harwood, C., & Ho, S. M. (2006). Apigenin suppresses cancer cell growth through ERβ. Neoplasia, 8(11), 896-904. https://doi.org/10.1593/neo.06538